SMA
SCLN

Simply Money Advisors’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Simply Money Advisors’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-90
Closed – – 149
2013
Q3 		$0 Hold
90
– – ﹤0.01% 409
2013
Q2 		$0 Buy
+90
New +$428 ﹤0.01% 432

Other funds holding SCLN

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Simply Money Advisors's SCLN Position: Q4 2013 in Review

Simply Money Advisors sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2013, closing a stake of 90 shares.

Simply Money Advisors first reported a position in SCLN in Q2 2013 and held it in 2 quarters. The position peaked at $0 in Q3 2013. 100 funds tracked by Wall St. Rank hold SCLN as of Q4 2013.

  • Simply Money Advisors reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2013 after selling out during the quarter.
  • Simply Money Advisors sold 90 Sciclone Pharmaceuticals Inc shares in Q4 2013.
  • Simply Money Advisors first reported a position in Sciclone Pharmaceuticals Inc in Q2 2013 and held it in 2 quarters.
  • Simply Money Advisors's Sciclone Pharmaceuticals Inc position peaked at $0 in Q3 2013.
  • 100 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2013.

Based on Simply Money Advisors's 13F filing for Q4 2013, filed 22 Jan 2014.